Related Experiment Video
Updated: May 12, 2026

Genetic Engineering of an Unconventional Yeast for Renewable Biofuel and Biochemical Production
Published on: September 20, 2016
High-Level Production of Ergothioneine in Yarrowia lipolytica via Systematic Metabolic Engineering Strategies
Qing Chen1, Jianan Li1, Kaixin Liu1
1School of Food Science and Pharmaceutical Engineering, Nanjing Normal University, Nanjing, Jiangsu, China.
Abstract:
Ergothioneine (ERG), a food-derived antioxidant and cytoprotectant, has broad application prospects in food, nutraceuticals, cosmetics, and biomedical fields. The growing market demand for ERG has driven the development of microbial cell factories as a sustainable production platform. However, the biosynthetic production of ERG faces challenges including poor substrate channeling, limited precursor supply, and potential inhibition by intracellular product accumulation. To construct a promising cell factory for high-level ERG production, firstly, the ERG biosynthetic pathway from Trichoderma reesei was heterologously expressed in Y. lipolytica Po1f (Δku70). Secondly, the application of Tregt1-Tregt2 fusion with a flexible (GGGGS)₂ linker and multi-copy integration led to an ERG production of 618.97 mg/L, an 83% improvement. Then, carbon flux was systematically redirected toward ERG production via modular engineering to enhance the precursor supply. Finally, fermentation conditions were optimized, resulting in an ERG production of 1075.27 mg/L in shake flask after 120 h fermentation. When scaled up to 5 L bioreactor, the strain achieved a final ERG production of 8.03 g/L within 168 h (47.79 mg/L/h), the highest reported to date without the supplementation of exogenous precursors. This study provides an effective strategy for utilizing Y. lipolytica as a microbial cell factory for ERG biosynthesis.
More Related Videos
07:59A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
10:41The Logic, Experimental Steps, and Potential of Heterologous Natural Product Biosynthesis Featuring the Complex Antibiotic Erythromycin A Produced Through E. coli
Published on: January 13, 2013
Related Concept Videos
Bioreactor Controls-III
Production of Antibiotics
Production of Pharmaceuticals
Upstream Processing
Production of Organic Acids